It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The new paper from the researchers, an un-peer-reviewed preprint, details what actually happened in the hydroxychloroquine arm—1,561 people got hydroxychloroquine, and 418 of them, 26.8 percent, were dead within 28 days. And 3,155 people got standard care without the drug; 788 of them died. That’s 25 percent. So: Hydroxychloroquine didn’t reduce mortality. Its use also correlated with longer time spent in the hospital and a higher likelihood of having to go on a mechanical ventilator. As the paper puts it: “not an effective treatment.”
So the so-called gold standard of drug trials is called an RCT, short for Randomized Controlled Trial. That means people sick with the thing you’re trying to study get put into one of two groups, or cohorts, from the very start. They either get the drug or they don’t, and no one—not the researchers, not the health care workers, not the participants in the study—knows who got what. (That’s called “double-blinding.”) And the researchers try to make those groups as similar as possible in every other way. They’re trying to eliminate all the possible external factors that could mess up the study.
originally posted by: Southern Guardian
There have been a number of promising treatments against COVID19 so it's any wonder why people are still hung up on Hydroxychloroquine?
The new paper from the researchers, an un-peer-reviewed preprint, details what actually happened in the hydroxychloroquine arm—1,561 people got hydroxychloroquine, and 418 of them, 26.8 percent, were dead within 28 days. And 3,155 people got standard care without the drug; 788 of them died. That’s 25 percent. So: Hydroxychloroquine didn’t reduce mortality. Its use also correlated with longer time spent in the hospital and a higher likelihood of having to go on a mechanical ventilator. As the paper puts it: “not an effective treatment.”
Source
[....]
To conduct these studies, the researchers made significant compromises. They could not obtain diagnostic testing for all patients, so included people who had symptoms but couldn’t get a test result. In the end, only 58% of the people in this study had diagnostic test results. The researchers mailed study drug or placebo to patients without examining them after they enrolled over the internet, meaning they used data patients self-reported. In the end, the study randomized 491 patients, 432 of whom contributed data to the final analysis.
The patients on hydroxychloroquine recovered 12% faster, or 0.27 points on a 10-point scale, but this difference was far from statistically significant. Patients on hydroxychloroquine also had side effects: 31% had upset stomachs and 21% diarrhea, both about double the rates in the placebo group, though no patients reported cardiac arrhythmias. Overall, adverse effects were reported by 43% of hydroxychloroquine patients and 22% of placebo patients.
The question is, given the study’s limitations, what weight should be given to the results?
“The study was of such low quality that it was fundamentally uninterpretable,” said Steven Nissen, a veteran clinical trialist at the Cleveland Clinic
Seems like the verdict is clear now.
originally posted by: IAMTAT
This is getting like the "Coffee is BAD for you...Coffee is GOOD for you..." thing.
originally posted by: myselfaswell
a reply to: Southern Guardian
I was under the impression from the start of this whole HCQ thing that it was meant to be used in conjunction with ZINC.
I thought the HCQ provided the capacity for the zinc to enter the cell.
originally posted by: myselfaswell
a reply to: Southern Guardian
I was under the impression from the start of this whole HCQ thing that it was meant to be used in conjunction with ZINC.
I thought the HCQ provided the capacity for the zinc to enter the cell.
The rest of us have the right to try it if we want.